California Alzheimer's medical trials

Is the M13 Virus the Next Alzheimer’s Cure?

Alzheimer’s disease is the most common type of dementia. Mainly affecting people over 65-years old, this progressive condition starts with memory problems. A person may forget how to get to work one day, and not be able to balance a checkbook the next day. Some time after, in addition to the memory issues, cognitive problems may arise, which may include not being able to conduct regular tasks at home and at work. Eventually, Alzheimer’s will render a person unable to take care of him or herself, recognize loved ones and need 24-hour care.

The most devastating concept to come to terms with when getting an Alzheimer’s diagnosis is that there is no cure for this condition. While there certain dementia medication or treatments that can help with certain symptoms, nothing is on the market yet to prevent this condition. This is why medical researchers and doctors are searching for an Alzheimer’s cure by conducting paid clinical trials in California. These medical studies need Alzheimer’s and dementia patients to assess whether a dementia treatment is effective. By enrolling, you will have access to try a potentially beneficial drug before anyone else.

M13 Virus as a Possible Cure for Alzheimer’s

In the latest medical news, it seems that a virus may also be able to eradicate Alzheimer’s disease! A live virus called M13 is being tested as a possible cure for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and others. The microbes of this virus, called bacteriophages, or phages, are found all over our universe and inside of our bodies, and are billions of years old. These microbes attack and kill bacteria, in particular Escherichia coli or E. coli, found in animals’ intestines. California Alzheimer's medical trials

In the repeated testing of rodents that have been injected with amyloid plaques that cause Alzheimer’s disease in humans, a scientist found that the M13 virus was able to dissolve up to 80 percent the plaques, and improve the rodents’ cognitive functions. It was also later found through test tube and animal experiments that these phages dissolved tau tangles associated with Alzheimer’s.

Limitations of the M13 Virus as a Cure

The animals in the study were injected with the live M13 virus through their nasal passages or into the brain, but these practices are not suitable for human subjects. Therefore, scientists tried to do the same procedure with an injection into the spinal card, like an epidural.

After further testing, the scientists realized that specific parts of the M13 virus, the GP3 proteins, are the ones responsible for eradicating the plaques. Therefore, they developed an antibody, called NPT088, to dissolve the proteins of E. coli, which worked. Although this new Alzheimer’s drug is still in the testing phase, scientists hope they can deliver it intravenously to patients one or two times a month to kill the plaques that cause Alzheimer’s disease.

While this treatment is not currently offered to patients yet, consider enrolling in a dementia medical trial to test other potential cures. For more information, contact Pacific Institute of Medical Research at (310) 208-7144 or go online to find out more information.

Leave a Reply